Abstract:
Lower sampling rates have been found to provide sufficient data for use in the method of U.S. Pat. Nos. 7,071,831, 7,616,125 and 7,791,491. The method of determining drowsiness includes the steps of receiving eye movement data collected at sampling rates as low as 20 Hz. The data is preferentially interpolated to provide a data set at a higher sampling rate in the order of 500 Hz. For each data point, values of amplitude and velocity of eye movement and whether the measures relate to eyelid opening or closing are derived. An algorithm is then used to obtain values of the amplitude to velocity ratios of eyelid opening and closing and using these values in an algorithm for providing a measure of drowsiness. With this method eyelid and eye movement may be monitored using any suitable technology or sensor including video or digital camera technology to identify and measure the appropriate ocular movements.
Abstract:
The disclosure features systems and methods for detecting a user's facial movement and expression, that include a plurality of radiation sources, a plurality of radiation detectors, where each radiation detector is paired with a different one of the radiation sources and configured to detect radiation emitted by its paired radiation source, and a controller connected to the radiation detectors and configured to receive signals corresponding to measurements of emitted radiation from each of the radiation detectors, determine, for each radiation source-detector pair, information about whether a radiation path between the source and detector is blocked by a portion of the user's face, and determine a facial movement or expression of the user based on the information.
Abstract:
A method of utilizing the chymotrypsin level of an individual as a measure of the success of neuropeptides, and peptides or digestive enzyme administration to such individuals, and in particular, as a prognosticative of potential neuropeptides, peptides, and digestive enzyme administration for persons having ADD, ADHD, Autism and other PDD related disorders. A method for determining the efficacy of neuropeptides, peptides, or digestive enzymes for the treatment of an individual diagnosed with a pervasive developmental disorder (PDD) comprises obtaining a sample of feces from an individual, determining a quantitative level of chymotrypsin present in the sample, and correlating the quantitative level of chymotrypsin determined to be present in the sample with the PDD to determine the efficacy of treating the individual with neuropeptides, peptides, or digestive enzyme administration.
Abstract:
An image forming apparatus (100) includes a biological information acquiring unit (402) that, upon accepting a print job transmitted by a user through a preset terminal device (103), identifies the terminal device (103) including a biological information detecting unit based on the terminal device's (103) identification information assigned to the print job, and acquires the user's biological information detected by the biological information detecting unit through a biological information receiving unit, a biological information determining unit (403) that determines whether or not the acquired biological information corresponds to reference biological information indicating that the user is in a hurry, and a calibration control unit (404) that, if the determination result shows that the acquired biological information corresponds to the reference biological information, disables regularly scheduled calibration at a time of, or during execution of the accepted print job.
Abstract:
An EEG POS system has an EEG device that detects electrical signals representing brain waves. A database of brain wave profiles represents a plurality of items to be identified. A live signal analyzer compares electrical signals from the EEG device with stored brain wave profiles in the database to identify entries in the database representing items that match the electrical signals from the EEG device, where items whose stored brain wave profiles match the electrical signals are considered identified items. A POS terminal is coupled to the live signal analyzer in order to log and tally items for a transaction.
Abstract:
Devices and methods are provided herein for aiding in the early diagnosis and remediation of conditions that range from unpleasant to disabling. Images are presented to viewers in an assembly that also eye-tracks their eyes during that process and executes software to identify visual signatures of conditions in the responses of the eyes. Also, responsive treatment for a thus-identified presentation of the condition can be effected in real time providing the patient with both a cause-and-effect perception of the presentation of the condition and means for correcting related ocular behaviors right when they occur.
Abstract:
A system analyzes neuro-response measurements including regional electroencephalography (EEG) measurements from subjects exposed to stimulus materials to determine locations in stimulus materials eliciting controlled attention and automatic attention. Additional stimulus materials are inserted into locations having salient attention attributes. In some examples, a challenging task is used to direct controlled attention onto a location and additional stimulus material is subtly presented in the location to benefit from automatic attention and salient attention measurements.
Abstract:
An operating method for controlling a wearable electronic device is provided which includes obtaining at least one environment variable of a current environment of the wearable electronic device, determining at least one appearance variable based on the environment variables by referring to information about different appearances predetermined to be suitable for different environmental conditions, and generating a first control signal for adjusting the appearance of at least one non-panel region of the wearable electronic device according to the appearance variables so that the adjusted appearance of the non-panel region of the wearable electronic device is adapted to a condition of the current environment.
Abstract:
Devices and methods are provided herein for aiding in the diagnosis of and response to conditions ranging from unpleasant to disabling. Images are presented to viewers and eye-tracking of their eyes during that process along with software analysis non-subjectively identify and quantify complex visual signatures formerly hidden in the responses of the eyes. This allows caregivers, when presenting these images to people to be evaluated for a condition, to identify, again with eye-tracking and software analysis, those signatures indicative of a presence or an absence of the condition. An associated remediative response provides treatment applicable to a real-time environment.
Abstract:
The visual and cognitive skills of a subject may be tested and/or trained by providing a visual stimulus to a subject. More particularly, a subject may be tested and/or trained when under a stress condition to determine the effect of a stress condition, such as a physical stress or a cognitive stress, on the subject's visual and sensory skills. A response may be received from a subject via an input device, the appropriateness of which may depend upon the stimulus provided to the subject. Behavioral information and other data regarding the performance of a subject and the possible effect of the stress condition may be recorded. Scoring may be based upon the speed, accuracy, and other aspects of the performance of a subject.